These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31526114)

  • 1. Analysis of Hepatitis B Virus Reactivation After Radiotherapy in Patients With Hepatocellular Carcinoma Using the Lyman NTCP Model.
    Li Z; Dong Y; Fan M; Yin Y; Zhu J; Li B; Huang W
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819875136. PubMed ID: 31526114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for hepatitis B virus reactivation after conformal radiotherapy in patients with hepatocellular carcinoma.
    Huang W; Zhang W; Fan M; Lu Y; Zhang J; Li H; Li B
    Cancer Sci; 2014 Jun; 105(6):697-703. PubMed ID: 24654677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
    Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Cheng SH; Tsai SY; Jian JJ; Lin YM; Cheng TI; Horng CF; Huang AT
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):156-62. PubMed ID: 12182986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus reactivation after three-dimensional conformal radiotherapy in patients with hepatitis B virus-related hepatocellular carcinoma.
    Kim JH; Park JW; Kim TH; Koh DW; Lee WJ; Kim CM
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):813-9. PubMed ID: 17524569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential dosimetric parameters of liver for the association with radiation-induced liver disease and virus reactivation: in regard to Kim et al. (Int J Radiat Oncol Biol Phys 2007;69:813-819).
    Cheng JC
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):961; author reply 961-2. PubMed ID: 18514794
    [No Abstract]   [Full Text] [Related]  

  • 6. Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease.
    Cheng JC; Wu JK; Lee PC; Liu HS; Jian JJ; Lin YM; Sung JL; Jan GJ
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1502-9. PubMed ID: 15590181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma.
    Xu ZY; Liang SX; Zhu J; Zhu XD; Zhao JD; Lu HJ; Yang YL; Chen L; Wang AY; Fu XL; Jiang GL
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):189-95. PubMed ID: 16542787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR4-dependant immune response, but not hepatitis B virus reactivation, is important in radiation-induced liver disease of liver cancer radiotherapy.
    Wu ZF; Zhou XH; Hu YW; Zhou LY; Gao YB; Peng XH; Yang XH; Zhang JY; Hu Y; Zeng ZC
    Cancer Immunol Immunother; 2014 Mar; 63(3):235-45. PubMed ID: 24337704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus reactivation after radiotherapy for hepatocellular carcinoma and efficacy of antiviral treatment: A multicenter study.
    Jun BG; Kim YD; Kim SG; Kim YS; Jeong SW; Jang JY; Lee SH; Kim HS; Kang SH; Kim MY; Baik SK; Lee M; Kim TS; Choi DH; Choi SH; Suk KT; Kim DJ; Cheon GJ
    PLoS One; 2018; 13(7):e0201316. PubMed ID: 30059513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease.
    Cheng JC; Liu HS; Wu JK; Chung HW; Jan GJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1150-6. PubMed ID: 15990021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load.
    Sohn W; Paik YH; Cho JY; Ahn JM; Choi GS; Kim JM; Kwon CH; Joh JW; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    J Viral Hepat; 2015 Jun; 22(6):539-50. PubMed ID: 25377516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
    Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
    Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial volume tolerance of the liver to radiation.
    Dawson LA; Ten Haken RK
    Semin Radiat Oncol; 2005 Oct; 15(4):279-83. PubMed ID: 16183482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling of Normal Tissue Complications Using Imaging and Biomarkers After Radiation Therapy for Hepatocellular Carcinoma.
    El Naqa I; Johansson A; Owen D; Cuneo K; Cao Y; Matuszak M; Bazzi L; Lawrence TS; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):335-343. PubMed ID: 29353652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
    Kim TH; Kim DY; Park JW; Kim SH; Choi JI; Kim HB; Lee WJ; Park SJ; Hong EK; Kim CM
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):225-31. PubMed ID: 17056199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of radiation-induced liver disease using the Lyman NTCP model.
    Dawson LA; Normolle D; Balter JM; McGinn CJ; Lawrence TS; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):810-21. PubMed ID: 12095546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.
    Dan JQ; Zhang YJ; Huang JT; Chen MS; Gao HJ; Peng ZW; Xu L; Lau WY
    Eur J Surg Oncol; 2013 Aug; 39(8):865-72. PubMed ID: 23597497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise.
    Gulliford SL; Partridge M; Sydes MR; Webb S; Evans PM; Dearnaley DP
    Radiother Oncol; 2012 Mar; 102(3):347-51. PubMed ID: 22119373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric factors and Lyman normal-tissue complication modelling analysis for predicting radiation-induced lung injury in postoperative breast cancer radiotherapy: a prospective study.
    Zhou ZR; Han Q; Liang SX; He XD; Cao NY; Zi YJ
    Oncotarget; 2017 May; 8(20):33855-33863. PubMed ID: 27806340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mathematical model for evaluating incidence of acute rectal toxicity during conventional or hypofractionated radiotherapy courses for prostate cancer.
    Strigari L; Arcangeli G; Arcangeli S; Benassi M
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1454-60. PubMed ID: 18990503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.